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Ncisseria meriirzgitidis and Neisseria gonorrkoeae infections 
in humans have traditionally been distinguished by 
their clinical manifestations and site of isolation. N. 
rrrerzingitidis usually causes meningococcemia and/or 
meningitis, while N. gonorrhoeae usually infects the 
anogenital mucous membranes. Nevertheless, the eco- 
logical niches of these two species occasionally overlap, 
and it has been observed that N. meriirlgitidis can 
colonize the anogenital tract in men and women, 
causing urethritis, proctitis and cervicitis; N. goriordioeae 
has been observed in the oropharyngeal mucous 
membranes, causing meningitis and pharyngitis [ 11. 
Between 1974 and 1993, the majority of cases 
of N rnenirigitidis urethritis were caused by strains 
belonging to serogroups A [2-3] and B [3,5,6]; isolated 
cases caused by strains belonging to serogroups C [7], 
29E [8] ,  X [91 and Y [3,6] and non-groupables [9] have 
also been published. This either is related to the greater 
ability of these serogroups to colonize the urethra, or 
else reflects the predominant serogroups in the com- 
munity. Epidemiologic studies show that in Spain 
a considerable increase in infections caused by N. 
rmiirigitidis serogroup C has occurred since 1990, the 
serotype 2b:Pl.3,5 being the most frequent [lo]. In our 
population this increase has been happening since 
1994. In this report we present a case of acute urethritis 
caused by N. meriirlgitidis C:2b:P1.2. 
In October 1996, a 12-year-old heterosexual male 
presented at the clinic at  his health center, with 
purulent urethral exudate and pain during micturition 
during the previous 8 days. The patient reported 
two episodes of urethritis of unknown etiology several 
years previously. He  had no regular partner and stated 
having had sexual intercourse with a prostitute, without 
fellatio or use of a condom, 20 days before presenting 
symptoms. His doctor referred him to the micro- 
biology laboratory for examination of urethral exudate. 
The patient received treatment with 1 g cefonicid every 
74 h for 2 days, after which he was asymptomatic. 
At the time of obtaining the sample, the patient 
presented little exudate. O n  direct microscopic exami- 
nation, 5-7 leukocytes/ x400 field were observed. No 
Gram-negative diplococci or other microorganisms 
were seen on the Gram stain. The exudate was streaked 
on Martin-Lewis agar (Biomedics, Madrid, Spain), 
vaginalis agar (made with Columbia agar (Becton 
Dickinson, Cockeysville, USA), protease peptone no. 3 
(Difco, Detroit, USA) and human blood), chocolate 
agar (Oxoid, Madrid, Spain) and Mycoplasma-Lyo 
(bioMkrieux, Marcy-L'Etoile, France). Direct immuno- 
fluorescence was performed for the detection of 
Chlamydia truckomatis antigen ( S p a  Company, San Josi., 
USA). The plates were incubated at 37°C for 48 h in 
5% COz. After 24 h, oxidase-positive colonies grew on 
Martin-Lewis agar and chocolate agar which on Gram 
stain had the appearance of Gram-negative diplococci. 
Identification was performed by the Api NH battery 
of biochemical tests (bioMerieux, Marcy-L'Etoile, 
France), with positive results for glucose oxidation and 
y-glutamyl transpeptidase (GGT). The strain was not 
P-lactamase-producing. It was presumed to be N 
gorzorrhoeae because of the kind of infection and the 
sugar oxidation. The microorganism was sent to the 
Carlos 111 Institute (Majadahonda, Madrid, Spain) for 
biotyping. No other microorganism was isolated from 
the urethra. The patient underwent further tests for the 
serologic determination of syphilis, HIV, and hepatitis 
viruses B and C; the results were negative in all cases. 
One month later, a follow-up of the urethral exudate 
was performed; no leukocytes were observed on direct 
microscopic examination, and the culture was negative. 
In the reference center, Carlos I11 Institute, bio- 
chemical identification with Api NH was positive for 
glucose oxidation and GGT production, and doubtful 
for maltose oxidation. Sugar oxidation was confirmed 
in trypticase cysteine medium, with positive results for 
glucose and maltose oxidation. Biotyping revealed the 
strain to be N. meningitidis. Monoclonal antibody typing 
identified it as N. meningitidis C:2b:P1.2. No crossover 
agglutinations with gonococci were found. 
No clinical or laboratory data are available on the 
women with whom the patient had sexual intercourse. 
N. rn~ningi~idi~ can be isolated from the naso- 
pharynx in 5 1 5 %  of individuals [l], with a greater 
proportion being observed in confined populations or 
certain groups. Janda et a1 [ l t ]  found a prevalence of 
42.5% meningococcal carriers in the nasopharynx in 
homosexual men attending a sexually transmitted 
diseases (STD) clinic. 
In the general population, the proportion of N. 
meningitidis isolated from the urethra ranges from 0.05% 
[7] to 0.07% [ 121, while Conde-Glez and Calder6n [5] 
found a rate of 0.4% in high-risk populations. In 
homosexual men, the proportion of meningococci 
isolated from the urethra ranges from 0.03% [7] to 0.7% 
[ll]. Maini et a1 [12] did not isolate any meningococci 
from 8992 urethral samples from heterosexual males, 
while McKenna et a1 [7] isolated this microorganism at 
a rate of 0.03%. 
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Meningococci may colonize the rectum of homo- 
sexual men (1.1% [7] to 3.1% [13]) and of 0.2% of 
women [13], and while Maini et a1 [12] did not isolate 
any meningococci from 15975 samples of cervical 
exudate, other authors report a rate of 0.03% [7]. These 
studies show that the presence of N. meniqitidis in the 
anogenital tract ranges widely, depending on the 
population studied. 
Despite the prevalence of N. meningitidis in the 
urethra, its capacity for producing urethritis is reIativeIy 
low. The first case published was in 1942 by Carpenter 
and Charles [2], but the majority of the cases described 
accumulated between the years 1974 and 1993 [3-151. 
From this date on, we have not found any cases 
reported in the databases consulted: Medline and 
Embase. Although McKenna et a1 171 did not find any 
variation between the prevalence and incidence of 
non-gonococcal Neisseria in anogenital samples in the 
period pre- and post-AIDS, our not finding any case of 
urethritis caused by meningococci from 1993 on may 
be related to the public awareness of HIV infection, as 
has been observed with other STDs such as gonococcal 
urethritis, which has been decreasing in our population 
since 1990 [16]. This may be more obvious among 
homosexuals, who had a greater incidence of urethritis 
caused by meningococci [7,11,13] as these comprise 
the population group which has taken greatest measures 
regarding the prevention of HIV infection. 
Urethritis caused by N. meningitidis may be either 
symptomatic, generally as exudate without dysuria 
[8,14], or indistinguishable from gonococcal urethritis 
[4-6,9], or asymptomatic [12]. 
Probably the most common route of transmission 
of meningococcal urethritis among heterosexuals was 
orogenital [4,9], while among homosexuals trans- 
mission was both orogenital and anogenital [7,12]. In 
the case described here, the route of transmission ofthe 
infection could not be determined, although it is clear 
from the medical history either that the meningococcus 
was colonizing the woman's cervix or that this was not 
a case of STD. 
The majority of cases of meningococcal urethritis 
described are caused by serogroup B; this may be due 
to it being more pathogenic in the genitoanal area, or 
else to it being the predominant serogroup in the 
population [ 1, lo]. 
Cases of maltose-negative N. meningitidis have 
occasionally been published [ 161. This appears to be 
related to the inactivation of a permease [17]. Our 
strain, while it did not ferment maltose in a rapid test, 
was positive when a more sensitive test was used. 
The clinical picture, site of isolation and identifi- 
cation may all contribute to initial confusion over 
urethritis due to N. meningitidis, and this indicates the 
need for typing of genital tract isolates. 
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Further increase in ciprofloxacin-resistant Campylobacfer 
jejuni/co/i in Styria, Austria 
CEin Microbiol Inject 1999; 5: 59-60 
Diarrhea caused by Campylobacterjejuni/coli is one of the 
most common bacterial intestinal infections in our 
region (province of Styria, 1.2 million inhabitants). 
Most of the cases appear to be mild and self-limiting, 
making antibiotic treatment necessary only under 
special conditions. Macrolides would be the reconi- 
mended antibiotics for CavnZlylobacter-related illness. 
Usually, however, ciprofloxacin is prescribed empirically 
in our region [I ,2]. 
At the Institute of Hygiene, University of Graz, 
Carnpylobacter spp. have been tested for resistance to 
nalidixic acid to detect the so-called NARTC (nalidixic 
acid-resistant thermophilic campylobacter) since 1988. 
Nalidixic acid-resistant strains were rare in 1988-90, 
but in the summer of 1991 we found a notable increase 
of resistant isolates, so we started to test ciprofloxacin 
and erythromycin routinely in 1992. Even during the 
first year we found a remarkable increase in cipro- 
floxacin resistance [3] and this has continued until now 
(Figure 1). 
To determine resistance patterns throughout the 
province of Styria, the three main Styrian laboratories 
have collected and evaluated data from the last 2 years 
(1996 and 1997). In total, 58 505 specimens of feces 
were examined and 1315 isolates of Campylobacter spp. 
were obtained from 1158 patients (specimen positivity 
2.25%). Species differentiation of 935 first isolates from 
individual patients revealed 94.1% C. jejuni and 5.9% 
C. coli. Nearly 30% of the isolates were from patients 
whose diarrheal illness had necessitated hospital treat- 
ment. The age distribution showed an excess of cases 
among children from 0 to 10 years (30%) and a second 
peak among the 20-30-year-olds. Most of these in- 
fections were acquired in our region; the number of 
infections acquired abroad was less than 5%. 
In all three laboratories, patterns of resistance of 
Campylobacter spp. to erythromycin (1 5 pg), nalidixic 
acid (30 pg) and ciprofloxacin (5 pg) were tested by 
disk diffusion performed on Mueller-Hinton agar 
(Oxoid, Basingstoke, UK) supplemented with 5% blood. 
All strains were incubated in a micro-aerophilic atmo- 
sphere at  42°C and read after 24-48 h. The following 
zone diameters (in mm) were used: erythromycin, 
>=23  susceptible, <=13 resistant; nalidixic acid, >=19 
susceptible, <=13 resistant; ciprofloxacin, >=21 
susceptible, < =15 resistant. In doubtful cases (nalidixic 
acid resistant and ciprofloxacin susceptible or 
intermediate), an additional Etest was performed 
according to the recommen-dations of Baker [4] for 
further confirmation and detection of type 2 mutants 
[5]. The following break-points of ciprofloxacin were 
used: MIC > = 4  mg/L, resistant; MIC < = 1  mg/L, 
susceptible. The results of these tests (only first isolates 
were used) are shown in Table 1. No connection was 
apparent between cipro-floxacin resistance and age or 
geographic distribution. A difference, however, occurred 
between C. jejuni and C. coli. Of  935 species-differen- 
tiated isolates, 880 were C. jejuni with a ciprofloxacin 
resistance of 27.4% and erythromycin resistance of 
0.7%, while the cipro-floxacin and erythromycin 
resistance of 55 strains of C. coli reached 47.3% and 
5.5%, respectively. 
The reason for this development may have been a 
regulation of the Austrian government (‘Geflugel- 
hygieneverordnung’), which was passed in the summer 
of 1991 and came into force on 1 January, 1992 with 
the aim of reducing the incidence of salmonellosis 
in Austria. This regulation laid down a number of 
measures, e.g. the testing of all poultry flocks for 
Salmonella spp. prior to slaughtering, with only 
Salmonella-free flocks being released for slaughter. This 
measure increasingly induced veterinarians to use anti- 
biotics in the poultry industry, especially enrofloxacin 
(Baytril), a quinolone closely related to ciprofloxacin. 
This development of resistance after the introduction of 
enrofloxacin in veterinary medicine was first described 
by Endtz et a1 in The Netherlands [6,7]; since that time, 
further publications reporting similar findings have 
become available [8-111. In Austria, enrofloxacin was 
introduced in the summer of 1989, but a large degree 
of overuse was initiated by the government regulation 
Table 1 Susceptibility of 1149 Campylobacter spp. (first 
isolates from individual patients) to erythromycin, nalidixic 
acid and ciprofloxacin 
Resistant to Resistant to Resistant to 
Number of erythromycm nalidixic acid ciprofloxacin 
isolates (“w (”/.I (“A) 
1996 568 1.4 25.9 25.2 
1997 581 0.3 34.9 34.1 
Total 1149 0.9 30.4 29.7 
